Xontogeny
2026-09-01xontogeny.com
Overview
What they do
Xontogeny is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies aimed at helping patients with serious diseases. It partners with entrepreneurs, providing leadership and operating experience to increase the probability of success in early drug and technology development. Xontogeny’s model allows affiliated companies to remain lean and virtual while benefiting from an experienced operational team, and helps founding scientists and entrepreneurs retain more control and equity while improving access to investment and development success.
xontogeny.com
What they look for
Xontogeny focuses on partnering with scientific founders and entrepreneurs to accelerate early-stage drug and life science technology development, providing leadership and operational support through a lean, virtual model. Its approach is designed to improve development success, enhance access to investment, and allow founders to retain more control and equity.
xontogeny.com
Stage
Seed, Series A, Series B+
xontogeny.com
Sectors
Healthcare
xontogeny.com
Based
Boston, US
xontogeny.com
Sources
2026-09-01xontogeny.comXontogeny, a New Accelerator Operating Company, Launches with a $25 Million Series A Financing…
2026-09-01xontogeny.comWe are a life sciences accelerator that collaborates with entrepreneurs, scientific founders…
2026-09-01xontogeny.comChris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies…
Portfolio, cheque size and the rest
The 29 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.
